Skip to content

VIC NEWS

From the blog

Pandemic

We’re not ready for the next pandemic.

SNAP

Customizing T Cell-Based Immunotherapies in a ‘SNAP’

Hangry Too VIC News Post IMG

New Research Shows That Bacteria Get “Hangry,” Too

E.coli

A swapped genetic code prevents viral infections and gene transfer

Clare-VIC

James Adeosun is a student at Clare College of the University of Cambridge who spent the summer working in the lab at VIC.

Clare college

Celebrating the 20th Year of Annual Research Program at VIC for Clare College Students

FASEB SUSAN RAJU PAUL

FASEB Journal publication from VIC’s Dr. Susan Raju Paul

NYTIMES_Callahn

NY Times Opinion Piece from Dr. Michael Callahan:

VIC-Pub-11323

Bifunctional cancer cell–based vaccine concomitantly drives direct tumor killing and antitumor immunity

VIC Update 1223

Optimized ACE2 decoys neutralize antibody-resistant SARS-CoV-2 variants through functional receptor mimicry and treat infection in vivo

DAVID_ALAGPULINSA

Keystone Symposium selects Dr. Alagpulinsa for 2023 Fellows Program

eOD-GT8-60mer-WEB

Novel HIV vaccine approach shows promise in first-in-human clinical trial

image

Dr. Poznansky Gives an Invited Research Talk about Latest Advances at VIC

Screen Shot 2022-11-09 at 1.21.39 PM

Investigating Cancer Immunotherapy Effects on COVID-19 Outcomes

new approaches to needleless vaccine delivery

New approaches to needle-less vaccine delivery

Screen Shot 2022-11-03 at 2.46.25 PM

A novel cuproptosis-related immune checkpoint gene signature identification and experimental validation in hepatocellular carcinoma

pHLIP-STING2

Cancer-seeking molecular delivery system could boost immunotherapy drug, research finds

VIC-polo-VII-2022-poster

VIC lab members enjoying social gatherings this summer.

DSC_1857VIC Update

Undergraduates enjoy a successful summer internship at VIC!

Cancer-Cell-Cover

Precise reconstruction of the TME using bulk RNA-seq and a machine learning algorithm trained on artificial transcriptomes.

unnamed

Evaluation of a Human T Cell-Targeted Multi-Epitope Vaccine for Q Fever in Animal Models of Coxiella burnetti Immunity.

VIC-NEWs-WMIF-MGH

2022 WMIF | The Dr. Is In | Leveraging Novel Mechanisms for Vaccine and Immunotherapy Development

David-V-leaving-party-5-26-22

David Verrill Goodbye Event

image001

EpiVax and Massachusetts General Hospital Advance on T cell-Targeted Epitope Vaccine for Q Fever

image002

COVID Vaccines, Therapeutics, Variants, Long COVID, Ability To Tackle the Next Pandemic

Screen-Shot-2022-04-26-at-12.52.09-PM

A new platform for immunotherapeutic RNA delivery to cancer cells

new-immune-cell-soldier-could-be-a-good-target-for-immunotherapy-360799-1280x720

Immune cell ‘Soldier’ identified as potential target for immunotherapy

VIC-News-Post-Dual-Drug-Treatment

Dual-drug treatment offers promise for advanced melanoma patients

Screen Shot 2022-04-02 at 6.05.44 PM

Novel drug combination may boost chemoimmunotherapy response in bladder cancer patients

1647962885954

Two-pronged immunotherapy treatment tested for effectiveness against glioblastomas

COH.DrDiamond-17LO

Recent data published indicates great hope in a newly developed COVID-19 vaccine

VIC-2-image

Restoring p53 function with mRNA nanoparticles and immune checkpoint blockade to enhance immunotherapy

Ukraine-Flag

181 Nobel Laureates condemn Vladimir Putin’s unprovoked and brutal invasion of Ukraine.

image001

Exciting research reveals new potential in investigating “hybrid immunity” against Covid-19 and evolving variant

Philanthropic support is critical to VIC’s success